Suppr超能文献

家族性帕金森病:对具有不同临床病理结果的相模原 PARK8(I2020T)原始家系的研究。

Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.

作者信息

Hasegawa Kazuko, Stoessl A Jon, Yokoyama Teruo, Kowa Hisayuki, Wszolek Zbigniew K, Yagishita Saburo

机构信息

Division of Neurology, National Hospital Organization, Sagamihara National Hospital, Japan.

出版信息

Parkinsonism Relat Disord. 2009 May;15(4):300-6. doi: 10.1016/j.parkreldis.2008.07.010. Epub 2008 Sep 18.

Abstract

BACKGROUND

Since the causative gene linked to PARK8 parkinsonism was identified as LRRK2, LRRK2 gene mutations have been found to occur in about 4% of patients with hereditary Parkinson disease (PD); this percentage is even higher in certain populations. Moreover, no clear clinical differences between PARK8-linked parkinsonism and sporadic PD have been identified. Neuropathologic findings have been diverse in PARK8 parkinsonism, but few of the clinicopathologic examinations have been performed in the same family tree. We aimed to describe PET and neuropathologic findings in members of the same family tree with PARK8 parkinsonism.

METHODS

We conducted PET of 2 subjects and neuropathologically examined 8 subjects in the same family from the Sagamihara district, the original source of PARK8-linked parkinsonism (I2020T mutation).

RESULTS

The results of the PET scans were virtually identical to those seen in sporadic PD. The neuropathologic study results showed pure nigral degeneration with no Lewy bodies in 6 cases. One case, however, showed the presence of Lewy bodies and was similar neuropathologically to conventional PD with Lewy bodies. Another case had multiple system atrophy pathology.

CONCLUSIONS

Our study of PARK8-linked parkinsonism affecting several members of the same pedigree shows that the same gene mutation can induce diverse neuropathologies, even if the clinical picture and PET findings are virtually identical.

摘要

背景

自从与PARK8型帕金森症相关的致病基因被确定为LRRK2以来,已发现LRRK2基因突变在约4%的遗传性帕金森病(PD)患者中出现;在某些人群中这一比例甚至更高。此外,尚未发现PARK8型帕金森症与散发性PD之间存在明显的临床差异。PARK8型帕金森症的神经病理学表现多样,但在同一谱系中进行的临床病理检查很少。我们旨在描述患有PARK8型帕金森症的同一谱系成员的PET和神经病理学表现。

方法

我们对来自相模原地区(PARK8型帕金森症的最初来源地,I2020T突变)的同一家庭中的2名受试者进行了PET检查,并对8名受试者进行了神经病理学检查。

结果

PET扫描结果与散发性PD的结果几乎相同。神经病理学研究结果显示,6例为单纯黑质变性,无路易小体。然而,有1例显示存在路易小体,神经病理学表现与传统的路易小体型PD相似。另一例有多系统萎缩病理改变。

结论

我们对影响同一谱系多名成员的PARK8型帕金森症的研究表明,即使临床表现和PET结果几乎相同,相同的基因突变也可诱发多种神经病理学改变。

相似文献

4
PARK8 LRRK2 parkinsonism.PARK8型富亮氨酸重复激酶2相关性帕金森病
Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. doi: 10.1007/s11910-006-0020-0.

引用本文的文献

本文引用的文献

4
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.导致无路易小体帕金森病的G2019S LRRK2突变。
J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):626-8. doi: 10.1136/jnnp.2006.107904. Epub 2007 Jan 8.
9
Lrrk2 and Lewy body disease.富含亮氨酸重复激酶2与路易体病
Ann Neurol. 2006 Feb;59(2):388-93. doi: 10.1002/ana.20731.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验